HYT
Get informed when a big investor buys or sells
+ FollowOvervalued by 125.5% based on the discounted cash flow analysis.
| Market cap | $1.41 Billion |
|---|---|
| Enterprise Value | $1.85 Billion |
| Dividend Yield | $0.93 (10.84%) |
| Earnings per Share | $0.91 |
| Beta | 0.6 |
| Outstanding Shares | 160,169,893 |
| P/E Ratio | 11.89 |
|---|---|
| PEG | 19.74 |
| Price to Sales | - |
| Price to Book Ratio | 0.96 |
| Enterprise Value to Revenue | 12.65 |
| Enterprise Value to EBIT | 13.79 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.28 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 32.50%▲ 12.68% |
|---|---|
| Total Invested | $444.06M▲ 73.86% |
| Investors Holding | 189▲ 16.00% |
No data
Provides critical analysis and 'revenue estimates' for tax legislation, directly influencing corporate tax structures and the overall tax burden, which are fundamental determinants of profitability and debt-servicing capacity for high-yield issuers.
Exercises paramount influence over taxation, trade, and entitlement spending, directly shaping corporate profitability, valuations, and the financial health of major sectors, which are all critical factors for high-yield corporate debt.
Directly controls the allocation of federal discretionary spending across all sectors, providing precise revenue streams for a multitude of companies, thereby having a direct and material impact on the credit quality of many high-yield issuers.
Exercises direct regulatory control over the pharmaceutical and biotech sectors (e.g., drug approvals) and influences labor costs, both profoundly impacting the profitability and creditworthiness of a wide range of high-yield debt issuers.
Directly influences corporate M&A, antitrust enforcement, and intellectual property laws, which are crucial for the competitive landscape, growth prospects, and financial health of many high-yield debt issuers.
Directly regulates the financial system, including the SEC (which oversees investment funds like BlackRock's), bank capital requirements, and credit markets, profoundly influencing the operational and regulatory environment for high-yield debt.
Possesses broad regulatory power over interstate commerce and critical sectors like telecommunications, technology, and aerospace, directly influencing the operational environment and creditworthiness of many high-yield issuers.
Directly controls regulations and policies that profoundly affect the financial health and valuation of companies in major energy, mining, and utility sectors, which are significant high-yield debt issuers.